The joint venture between Cargill and dms-firmenich, called Avansya, has announced that EverSweet stevia sweetener has received a positive safety opinion from the European Food Safety Authority and the UK Food Standards Agency.
The joint venture between Cargill (Wayzata, MN) and dms-firmenich (Heerlen, NL), called Avansya, has announced that EverSweet stevia sweetener has received a positive safety opinion from the European Food Safety Authority (EFSA) and the UK Food Standards Agency (FSA). The opinion brings the sweetener one step closer to commercialization in the European Union and UK.
To make EverSweet, fermentation is used to extract Reb M and Reb D, the sweetest and cleanest tasting components of the stevia leaf which comprise only 1% of the leaf. This process, the firms explain in a press release, reduces water usage, has a minimal impact on land, and a lower carbon footprint compared to producing acres of stevia plants. These environmental benefits were quantified in a third-party life cycle assessment. EverSweet is already available U.S., Canada, and Mexico. Final authorization from EFSA and FSA is expected in 2024.
“We are thrilled that our European customers will soon gain access to this advanced, zero-calorie sweetener, and look forward to collaborating with them to bring consumers a new generation of products that reflect their priorities around health, nutrition, indulgence, and sustainability,” said Andrew Ohmes, CEO Avansya, in a press release. “Consumers don’t want to compromise on any of these points; with EverSweet, they don’t have to – it’s the sweetness solution that brings it all together.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
2 Commerce Drive
Cranbury, NJ 08512